GlobalData on MSN2d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
PharmiWeb3d
GSK and Oxford establish the GSK-Oxford Cancer Immuno-Prevention Programme to advance novel cancer research
GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...
GSK and Oxford researchers to create cancer vaccine to stop disease developing
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
GSK, Oxford to establish GSK-Oxford Cancer Immuno-Prevention Programme
GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...
FierceBiotech3d
GSK offers up to £50M to conduct cancer vaccine research with the University of Oxford
British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...
pharmaphorum3d
GSK backs £50m Oxford University cancer vaccine programme
The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...
Yahoo Finance3d
GSK and Oxford researchers to create cancer vaccine to stop disease developing
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...